Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by knowsbeston Jan 06, 2021 10:35am
112 Views
Post# 32232418

RE:40 testing sites up and running & projected revenue

RE:40 testing sites up and running & projected revenue "These testing sites are performing 40x96=3840 testing per day, generating3840x$95 USD 364,800 and Canadian $463,296 per day, $13,898,880 per month and $166,786,560 per year. Medivolve projected EBTIDA is 55% and with that $91,732,608 EBTIDA profit per year."

 OK math based on projections ..exelent good multiplication skills 

Now answer the following :

1.Are projections actual,confirmed ,verifyied and sertified numbers ?
2.What are the true cost associated with those numbers .
3.What are the legal liabilities 
4.Why is the SP .39
5.Why no insider buying 
6.why no coverage by major brokerage 



<< Previous
Bullboard Posts
Next >>